secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fresh Tracks Therapeutics, Inc. (—)
CIK:        0000819050
Form:       8-K
Filed at:   2023-07-25T23:59:59+00:00
Accession:  0000819050-23-000057
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Robert Brown resigns from Fresh Tracks board; board reduced to 3 members; Nasdaq compliance regained
--------------------------------------------------------------------------------

- Robert B. Brown resigned from the Board effective July 24, 2023; no disagreement with operations or policies.
- Board reduced minimum number of directors from 4 to 3 via amended bylaws, and reduced board size to 3.
- Company regained Nasdaq compliance for independent director and audit committee requirements under Rule 5605.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/819050/000081905023000057/0000819050-23-000057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/819050/000081905023000057/frtx-20230724.htm
  HTML page:      https://secwatch.observer/filing/0000819050-23-000057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer